跳至主要内容
临床试验/IRCT201612072394N35
IRCT201612072394N35已完成2 期

Effects of consumption of probiotic on symptom severity , quality of life, plasma ACTH and serum cortisol in patients with generalized anxiety disorder

Vice-chancellor for research, Iran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • DSM-V diagnosed of GAD; Adults between 18 and 65 years old; Willing to participate.
  • exclusion criteria: Having illness including liver disease and kidney disease, diabetes, immune deficiency, etc; Having psychological illnesses including psychosis, Suicidal ideation, bipolar disorder and major depression; People who are expected to have limited partnerships such as forgetfulness and pregnancy; Taking any medication in the previous 1 month; Taking any medication related to psychiatric diseases including antidepressants, antipsychotics, etc. (maximum of two times per week) and antibiotics in the previous 1 month; Taking any supplement including probiotic supplement, fiber, prebiotics, omega-3, vitamins and minerals in the previous 1 month; Consumption of fermented foods (except yogurt), such as sour cream, acidophilus milk, kefir and some cheeses such as blue vein cheese or Swiss cheese in the previous 1 month; substance abuse; The compliance less than 80%.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for research, Iran University of Medical Sciences

相似试验